nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Catching the Silent Culprits: TERT Promoter Mutation Screening of Minimally Invasive Follicular and Oncocytic Thyroid Carcinoma in Clinical Practice
|
Hellgren, L. Samuel |
|
|
35 |
4 |
p. 411-418 |
artikel |
2 |
Cauda Equina Neuroendocrine Tumors with Ganglioneuromatous Elements are Best Classified as Composite Gangliocytoma/Neuroma and Neuroendocrine Tumor (COGNET)
|
Dogukan, Fatih Mert |
|
|
35 |
4 |
p. 453-456 |
artikel |
3 |
Clinicopathological Features of Epstein-Barr Virus-Positive Neuroendocrine Carcinoma: Analysis of Twenty-Two Cases
|
Zhang, Xiao-Ying |
|
|
35 |
4 |
p. 362-371 |
artikel |
4 |
Clinicopathologic and Molecular Analysis of 15 Pediatric and Young Adult Patients with High-Grade Non-anaplastic Thyroid Carcinoma
|
Whaley, Rumeal D. |
|
|
35 |
4 |
p. 397-410 |
artikel |
5 |
Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management
|
Mete, Ozgur |
|
|
35 |
4 |
p. 293-308 |
artikel |
6 |
Correction: Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management
|
Mete, Ozgur |
|
|
35 |
4 |
p. 309-310 |
artikel |
7 |
Effective Preparation of FFPE Tissue Samples for Preserving Appropriate Nucleic Acid Quality for Genomic Analysis in Thyroid Carcinoma
|
Okubo, Yoichiro |
|
|
35 |
4 |
p. 372-384 |
artikel |
8 |
Endocrine Pathology Society Hubert Wolfe Award for 2024: Call for Nominations
|
|
|
|
35 |
4 |
p. 457 |
artikel |
9 |
Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres)
|
Mattiolo, Paola |
|
|
35 |
4 |
p. 354-361 |
artikel |
10 |
High-Grade Progression, Sarcomatous Transformation, and/or Metastasis of Pituitary Neuroendocrine Neoplasms (PitNENs): The UCSF Experience
|
Terry, Merryl |
|
|
35 |
4 |
p. 338-348 |
artikel |
11 |
Insights into Biologic Evolution of Grade 3 Neuroendocrine Tumors Reflect Classification Challenges
|
Mete, Ozgur |
|
|
35 |
4 |
p. 311-312 |
artikel |
12 |
Mitochondrial Proteome Defined Molecular Pathological Characteristics of Oncocytic Thyroid Tumors
|
Li, Lu |
|
|
35 |
4 |
p. 442-452 |
artikel |
13 |
Multilineage Pituitary Neuroendocrine Tumors Expressing TPIT and SF1: A Clinicopathological Series of Six Tumors
|
Asa, Sylvia L. |
|
|
35 |
4 |
p. 349-353 |
artikel |
14 |
Progression of Low-Grade Neuroendocrine Tumors (NET) to High-Grade Neoplasms Harboring the NEC-Like Co-alteration of RB1 and TP53
|
Joseph, Nancy M. |
|
|
35 |
4 |
p. 325-337 |
artikel |
15 |
Rapid Evolution of Metastases in Patients with Treated G3 Neuroendocrine Tumors Associated with NEC-Like Transformation and TP53 Mutation
|
Kasajima, Atsuko |
|
|
35 |
4 |
p. 313-324 |
artikel |
16 |
SATB2 is an Emergent Biomarker of Anaplastic Thyroid Carcinoma: A Series with Comprehensive Biomarker and Molecular Studies
|
Nkosi, Dingani |
|
|
35 |
4 |
p. 432-441 |
artikel |
17 |
The Molecular Classification of Pheochromocytomas and Paragangliomas: Discovering the Genomic and Immune Landscape of Metastatic Disease
|
de Bresser, Carolijn J. M. |
|
|
35 |
4 |
p. 279-292 |
artikel |
18 |
The Potential Utility of RAS Q61R Immunohistochemistry as a Screening Tool in Pre-operative Fine Needle Aspirates of Medullary Thyroid Carcinoma
|
Deyette, Brea |
|
|
35 |
4 |
p. 385-396 |
artikel |
19 |
Unravelling the Reasons Behind Limited Response to Anti-PD Therapy in ATC: A Comprehensive Evaluation of Tumor-Infiltrating Immune Cells and Checkpoints
|
Boruah, Monikongkona |
|
|
35 |
4 |
p. 419-431 |
artikel |